用户名: 密   码:
注册 | 忘记密码?
专利信息
查询条件 展开筛选条件
  • [专利权人] 包含 'THE REGENTS OF THE UNIVERSITY OF CALIFORNIA'
排序 翻到页码
标题标题2专利权人发明人附图摘要摘要2优先权号IPC专利类型
首页123456下页尾页148 条记录, 当前第1/15页。
公开号 公开日 申请号 申请日
1. US20140088156A1 2014/3/27
专利标题:Sorafenib derivatives as seh inhibitors 法律状态
The present invention provides compounds for the inhibition of soluble epoxide hydrolase and associated disease conditions.


2. US8609843B2 2013/12/17 US13/420299 2012/3/14
专利标题:Photoactive metal nitrosyls for blood pressure regulation and cancer therapy 法律状态
Disclosed are nitric oxide delivery agents and methods of their use more specifically to photoactive compounds which are able to perform targeted delivery of nitric oxide in vitro and in vivo and are useful for medicinal applications including but not limited to blood pressure regulation and cancer treatment.


3. US20130303548A1 2013/11/14 US13/988972 2011/11/22
专利标题:Indication for use of niacin (nicotinic acid) for treatment, prevention and reversal of fatty liver disease 法律状态
Niacin prevents and/or reverses the development of experimental hepatic steatosis deposition of triglycerides in liver and serum of individuals deposition of total cholesterol in liver and serum in individuals and inhibit liver lipid peroxidation and oxidative stress in individuals at risk of developing fatty liver disease or NAFLD. In cultured human hepatocytes niacin inhibits alcohol-induced fat accumulation.


4. WO2013169907A1 2013/11/14
专利标题:Alpha 7 nicotinic acetylcholine allosteric modulators, their derivatives and uses thereof 法律状态
The present application is related to compounds represented by Formula I which are novel positive allosteric modulators of al nAChRs. The application also discloses the treatment of disorders that are responsive to enhancement of acetylcholine action on al nAChRs in a mammal by administering an effective amount of a compound of Formula I.


5. US20130289252A1 2013/10/31 US13/772283 2013/2/20
专利标题:Compositions and methods for the delivery of nitric oxide 法律状态
H-NOX proteins are mutated to exhibit improved or optimal kinetic and thermodynamic properties for blood gas NO delivery. The engineered H-NOX proteins comprise mutations that impart altered NO or O2 ligand-binding relative to the corresponding wild-type H-NOX domain and are operative as physiologically compatible mammalian blood NO gas carriers. The invention also provides pharmaceutical compositions kits and methods that use wild-type or mutant H-NOX proteins for the treatment of any condition...


6. US20130289270A1 2013/10/31 US13/978384 2012/1/6
专利标题:Amination of aryl alcohol derivatives 法律状态
Embodiments of the invention provide methods and materials for chemical cross-coupling reactions that utilize aryl alcohol derivatives as cross-coupling partners. Embodiments of the invention include methods for the amination of aryl sulfamates and carbamates which are attractive cross-coupling partners particularly for use in multistep synthesis. Illustrative embodiments include versatile means to use simple derivatives of phenol as precursors to polysubstituted aryl amines as exemplified by a ...


7. US20130267506A1 2013/10/10 US13/877619 2011/10/24
专利标题:Therapeutic compositions for diabetic symmetrical polyneuropathy 法律状态
Compositions for therapy of a diabetic symmetrical polyneuropathy a subject in need thereof the compositions comprising: an effective amount of a muscarinic acetylcholine receptor antagonist exemplified by pirenzepine telenzepine atropine or derivatives thereof or salts thereof or analogs thereof or derivatives thereof and a pharmacologically acceptable carrier. The composition may be injectable or alternatively may be applied topically or alternatively may be delivered orally. A suitable topica...


8. US8546607B2 2013/10/1
专利标题:Cross-coupling of phenolic derivatives 法律状态
Embodiments of the invention provide methods and materials for chemical cross-coupling reactions that utilize unconventional phenol derivatives as cross-coupling partners. Embodiments of the invention can be used to synthesize a variety of useful organic compounds for example the anti-inflammatory drug flurbiprofen.


9. US20130231279A1 2013/9/5 US13/812850 2011/7/30
专利标题:Oxytocin treatment to improve memory and modify blood glucose 法律状态
The disclosure provides a method for enhancing memory of a subject lowering blood glucose levels in a subject and treating schizophrenia the methods comprise intranasally administering to the subject an amount of a oxytocin peptide or analogue thereof having a beneficial effect.


10. EP1896394B1 2013/5/29
专利标题:Substituted enaminones as nicotinic acetylcholine receptor modulators 法律状态



首页123456下页尾页148 条记录, 当前第1/15页。

下载范围

下载第 条记录。

下载内容

题录信息 专利全文